Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
omega 3 fatty acid/bröstcancer
Länken sparas på Urklipp
Sida 1 från 33 resultat
Adaptive Symptom Care Using Fish-Based Nutritional Directives Post Breast Cancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Altering Lipids for Tolerance of Aromatase Inhibitor Therapy
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Study of Moderate Dose Omega 3 Fatty Acid Supplement in Premenopausal Women at High Risk for Breast Cancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Pregnancy and breast feeding are protective when they occur at an early age, typically at an age less than 30. The influence of pregnancy on breast cancer risk is not fully understood, and little is known about modulation of the breast microenvironment during pregnancy and its influence on risk.
Breast, Omega 3 Free Fatty Acid, Ph 0
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Prospective, single arm, short term study with correlative biomarker endpoints. Two hundred (200) newly diagnosed breast cancer patients will be recruited to participate in a short term (30 day) Phase 0 biomarker evaluation study prior to surgical resection. Patients will be receive fish Oil
Diagnostic Potential of Hypermethylated DNA in Colorectal Cancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Colorectal cancer (CRC) is one of the most common forms of cancer and the second leading cause of cancer-related deaths in the western world, accounting for the annual death of 215.000 europeans in 2012 and an estimated 50.310 Americans in 2014.
Sporadic CRC develops through the accumulation of
Effects of Omega-3 Fatty Acids on Risk Factors for Breast Cancer in Pre-menopausal Women
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Non-pregnant, non-lactating women aged 18+ were recruited by way of posters, to take part in a dietary intervention study that was examining the effects of dietary fat level and fat type on risk factors associated with breast cancer. Women who were normally menstruating, consumed either their
Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Phase 2, Single Centre, Open-label 2 Arm Randomized Trial. The intervention group will receive a daily dose of Vitamin D, Omega-3-fatty acids, Vitamin B6, and Vitamin B12. The reference group will have usual care.
Dose of Nutraceuticals: Vitamin D 2000 IU oral once daily, Vitamin B6 100 mg oral once
Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
PRIMARY OBJECTIVES:
I. To determine the efficacy of the complementary therapy omega-3 fatty acid (n-3 PUFA) supplementation in preventing aromatase inhibitor-induced arthralgias (AIIAs).
SECONDARY OBJECTIVES:
I. To prospectively define the population most at risk for developing AIIAs by the
Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Prospective, comparative, three arm, short term, non-interventional study with correlative biomarker endpoints. Sixty (60) obese (≥ 30 BMI) newly diagnosed ER+ postmenopausal breast cancer patients will be recruited to participate in a short term (30 day) Phase 0 biomarker evaluation study prior to
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
PRIMARY OBJECTIVE:
I. To collect preliminary statistical data (mean changes and standard deviations) on two omega-3 supplementation (omega-3 fatty acid) regimens (1.65 g/day and 3.3 g/day) compared to placebo for reducing cancer-related fatigue (CRF) in fatigued breast cancer survivors.
OUTLINE:
Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Metformin is a medication used to treat and prevent diabetes and omega-3 fatty acids has been shown to lower cholesterol and improve cardiovascular health. Research has shown that Metformin and omega-3 fatty acids may also be effective in preventing cancer. In this study, we want to find out what
Dietary Intakes and Periodontal Outcomes After Sanative Therapy
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Oral health, specifically the retention of teeth, is inextricably and positively linked with nutritional status of an individual. The emerging inter-relationships among obesity, type II diabetes metabolic syndrome, acute coronary syndrome and/or breast cancer with the etiology of periodontal disease
Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The study aims to determine biological changes that occur with a 12 month intervention of low (~0.9 g EPA+DHA/day) vs high dose (~5.4 g EPA+DHA/day) of omega 3 polyunsaturated fatty acids (PUFAs) in women survivors of hormone unresponsive breast cancer. The objectives of the trial are to develop
VITamin D and OmegA-3 TriaL: Effects on Mammographic Density and Breast Tissue
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Mammographic density is one of the strongest risk factors for breast cancer. It is predictive of breast cancer risk for at least 10 years in the futue and has been suggested as a surrogate marker of breast cancer risk. Several states now mandate release of mammographic density data to women.
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
